Panel-based pharmacogenetic genotyping for Prescription Drug Use

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UF Health at the University of Florida, Gainesville, FLPrescription Drug Use+1 MorePanel-based pharmacogenetic genotyping - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if a preemptive clinical pharmacogenetic test can improve patient outcomes by better personalized drug therapy. Data from this trial will also help understand when and how to implement this innovative healthcare technology into clinical care.

Eligible Conditions
  • Prescription Drug Use
  • Pharmacogenetic Testing

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Pharmacogenetic Testing
1
Standardized Discharge Prescription
1
ManNAc

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12-14 months

12-14 months
Change in Patient Treatment Satisfaction Measured by the Treatment Satisfaction Questionnaire for Medication (TSQM)

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Pharmacogenetic Testing
1
Standardized Discharge Prescription
2
ManNAc

Trial Design

1 Treatment Group

Immediate panel-based pharmacogenetic genotyping
1 of 1

Experimental Treatment

492 Total Participants · 1 Treatment Group

Primary Treatment: Panel-based pharmacogenetic genotyping · No Placebo Group · N/A

Immediate panel-based pharmacogenetic genotyping
DiagnosticTest
Experimental Group · 1 Intervention: Panel-based pharmacogenetic genotyping · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12-14 months

Who is running the clinical trial?

University of FloridaLead Sponsor
1,261 Previous Clinical Trials
698,948 Total Patients Enrolled
National Human Genome Research Institute (NHGRI)NIH
254 Previous Clinical Trials
278,677 Total Patients Enrolled
Julio Duarte, PharmD, PhDPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
111 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have certain medical conditions, such as depression, acid reflux, ulcers, heart problems, arthritis, high cholesterol, blood clots, or have had surgery or significant injuries that may affect your ability to participate in the study.
References

Frequently Asked Questions

Are there any available opportunities for individuals to join this trial?

"Clinicaltrials.gov reports that this particular medical trial is still recruiting volunteers. This study was initially posted on the 1st of August 2022 and saw its last update on the 5th of August 2022." - Anonymous Online Contributor

Unverified Answer

How many individuals are eligible for this medical experiment?

"Indeed, research on clinicaltrials.gov affirms that this experiment is actively recruiting participants. The study was first uploaded to the website on August 1st 2022 and has been recently revised for accuracy as of August 5th 2022. As such, 492 individuals across a single location are needed in order to complete it successfully." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top